This inventor holds 3 USPTO granted patents. Top assignee: Harvard College. Active years: 1998-2004.
Company Filing History:
Years Active: 1998-2004
Title: Hwai-Jong Cheng: Innovator in EPH Receptor Ligands
Introduction
Hwai-Jong Cheng is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biochemistry, particularly in the area of EPH receptor ligands. With a total of 3 patents, Cheng's work has implications for the understanding and manipulation of tissue formation in vertebrates.
Latest Patents
Cheng's latest patents focus on the discovery of a novel EPH receptor ligand known as "Elf-1." This protein plays a crucial role in the formation and maintenance of ordered spatial arrangements of differentiated tissues in vertebrates. The applications of this invention extend to generating and maintaining various vertebrate tissues both in vitro and in vivo.
Career Highlights
Hwai-Jong Cheng is affiliated with Harvard College, where he conducts his research and development. His work has garnered attention for its innovative approach to understanding tissue differentiation and organization.
Collaborations
Cheng collaborates with John G Flanagan, a fellow researcher, to further explore the potential applications of EPH receptor ligands in biomedical research.
Conclusion
Hwai-Jong Cheng's contributions to the field of biochemistry through his patents on EPH receptor ligands highlight the importance of innovation in understanding complex biological processes. His work continues to pave the way for advancements in tissue engineering and regenerative medicine.